https://www.selleckchem.com/pr....oducts/elexacaftor.h
01 per 10,000 person-weeks) in the NI cohort. The protective effect of
<i>Arsenicum album</i> 30C against laboratory confirmed COVID-19 was 74.40% (95% CI, 55.08 to 85.41) 18 cases per 6,590 (3.32 per 10,000 person-weeks) in the
<i>Arsenicum album</i> 30C group versus 38 cases per 3,590 (11.85 per 10,000 person-weeks) in the NI cohort. The use of
<i>Arsenicum album</i> 30C was associated with some protection against probable and laboratory-confirmed COVID-19 in a containment-zone setting. Randomized controlled trials are nee
Like
Comment
Share
